oxybutynin has been researched along with Menopause in 12 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Menopause: The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age.
| Excerpt | Relevance | Reference |
|---|---|---|
| " A transdermal patch of Ethinyl Estradiol (EE) nanoparticles was aimed to provide sustained release of the drug and lower dosage frequency." | 1.91 | Formulation and characterization of nanoparticle-based ethinyl estradiol transdermal drug delivery system for contraception and menopausal disorders. ( Afzal, A; Bibi, S; Hussain, T; Javaid, Z; Kainat, -; Tabassum, M; Zaman, K, 2023) |
| "Type of menopause was not significantly associated with cognitive function." | 1.40 | Impact of a premature menopause on cognitive function in later life. ( Amieva, H; Ancelin, ML; Berr, C; Carrière, I; Ritchie, K; Rouaud, O; Ryan, J; Scali, J, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (75.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Guttuso, T | 1 |
| Moore, KH | 1 |
| Goldstein, M | 1 |
| Hay, D | 1 |
| Tapp, AJ | 1 |
| Cardozo, LD | 1 |
| Versi, E | 1 |
| Cooper, D | 1 |
| Afzal, A | 1 |
| Zaman, K | 1 |
| Tabassum, M | 1 |
| Kainat, - | 1 |
| Bibi, S | 1 |
| Javaid, Z | 1 |
| Hussain, T | 1 |
| Cintron, D | 1 |
| Beckman, JP | 1 |
| Bailey, KR | 1 |
| Lahr, BD | 1 |
| Jayachandran, M | 1 |
| Miller, VM | 1 |
| Bezwada, P | 1 |
| Shaikh, A | 1 |
| Misra, D | 1 |
| Gera, R | 1 |
| Tayeh, S | 1 |
| Chehade, HE | 1 |
| Mokbel, K | 1 |
| Ryan, J | 1 |
| Scali, J | 1 |
| Carrière, I | 1 |
| Amieva, H | 1 |
| Rouaud, O | 1 |
| Berr, C | 1 |
| Ritchie, K | 1 |
| Ancelin, ML | 1 |
| Mohammed, K | 1 |
| Abu Dabrh, AM | 1 |
| Benkhadra, K | 1 |
| Al Nofal, A | 1 |
| Carranza Leon, BG | 1 |
| Prokop, LJ | 1 |
| Montori, VM | 1 |
| Faubion, SS | 1 |
| Murad, MH | 1 |
| Owen, CM | 1 |
| Pal, L | 1 |
| Mumford, SL | 1 |
| Freeman, R | 1 |
| Isaac, B | 1 |
| McDonald, L | 1 |
| Santoro, N | 1 |
| Taylor, HS | 1 |
| Wolff, EF | 1 |
| Połać, I | 1 |
| Borowiecka, M | 1 |
| Wilamowska, A | 1 |
| Nowak, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effects of Estrogen Replacement on Atherosclerosis Progression in Recently Menopausal Women[NCT00154180] | Phase 4 | 728 participants (Anticipated) | Interventional | 2005-09-30 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for oxybutynin and Menopause
| Article | Year |
|---|---|
Effective and clinically meaningful non-hormonal hot flash therapies.
Topics: Actaea; Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Cyclohexanols; Desvenlafaxine Succinat | 2012 |
The Effect of Transdermal Estrogen Patch Use on Cardiovascular Outcomes: A Systematic Review.
Topics: Administration, Cutaneous; Cardiovascular Diseases; Estrogen Replacement Therapy; Estrogens; Female; | 2017 |
Does Transdermal Testosterone Increase the Risk of Developing Breast Cancer? A Systematic Review.
Topics: Administration, Cutaneous; Breast Neoplasms; Female; Humans; Menopause; Risk Factors; Sexual Dysfunc | 2018 |
Oral vs Transdermal Estrogen Therapy and Vascular Events: A Systematic Review and Meta-Analysis.
Topics: Administration, Oral; Estrogen Replacement Therapy; Evidence-Based Medicine; Female; Humans; Menopau | 2015 |
5 trials available for oxybutynin and Menopause
| Article | Year |
|---|---|
The treatment of detrusor instability in postmenopausal women with oxybutynin chloride: a double blind placebo controlled study.
Topics: Female; Humans; Mandelic Acids; Menopause; Middle Aged; Parasympatholytics; Urinary Incontinence | 1990 |
The treatment of detrusor instability in post-menopausal women with oxybutynin chloride: a double blind placebo controlled study.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Female; Humans; Mandelic Acids; Menopause; Middle Aged | 1990 |
Plasma orexin A levels in recently menopausal women during and 3 years following use of hormone therapy.
Topics: Administration, Cutaneous; Administration, Oral; Body Mass Index; Energy Metabolism; Estradiol; Estr | 2017 |
Effects of hormones on skin wrinkles and rigidity vary by race/ethnicity: four-year follow-up from the ancillary skin study of the Kronos Early Estrogen Prevention Study.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Black or African American; Double-Blind Meth | 2016 |
Coagulation and fibrynolitic parameters in women and the effects of hormone therapy; comparison of transdermal and oral administration.
Topics: Administration, Oral; Blood Coagulation; Cardiovascular Diseases; Drug Combinations; Dydrogesterone; | 2013 |
3 other studies available for oxybutynin and Menopause
| Article | Year |
|---|---|
Formulation and characterization of nanoparticle-based ethinyl estradiol transdermal drug delivery system for contraception and menopausal disorders.
Topics: Administration, Cutaneous; Contraception; Drug Delivery Systems; Ethinyl Estradiol; Humans; Menopaus | 2023 |
Impact of a premature menopause on cognitive function in later life.
Topics: Aged; Aged, 80 and over; Cognition; Dementia; Estradiol; Estrogen Replacement Therapy; Estrogens; Fe | 2014 |
Addendum: Transdermal estrogen (Med Lett Drugs Ther 2012;54:41).
Topics: Administration, Oral; Estrogen Replacement Therapy; Estrogens; Humans; Menopause; Transdermal Patch | 2012 |